Latest BRCA2 Stories
Patenting pure genes linked to diseases is unconstitutional and slows down research progress, civil liberties advocates claim. American Civil Liberties Union Executive Director Anthony Romero says constitutional rights to knowledge about the human body and to make pertinent healthcare decisions are at stake when private companies are allowed to hold patents on genes found responsible for diseases, CNN reported Wednesday. The ACLU and Yeshiva University's law school filed suit in U.S.
BETHESDA, Md., May 12 /PRNewswire-USNewswire/ -- The American College of Medical Genetics (ACMG) has joined the Association for Molecular Pathology, the College of American Pathologists, and the American Society for Clinical Pathology in a lawsuit filed today charging that patents on the human genes associated with breast and ovarian cancer interfere with diagnostic testing, stifle research and limit women's options regarding their health care.
Gene Patents Stifle Patient Access To Medical Care And Critical Research NEW YORK, May 12 /PRNewswire-USNewswire/ -- The American Civil Liberties Union and the Public Patent Foundation at Benjamin N.
Women whose cells harbor harmful mutations in the BRCA genes are likely to view preventive mastectomy as the best way to reduce their risk and fears of developing breast cancer, despite other, less drastic options available.
U.S. cancer researchers say they have identified an area on chromosome 6 that's strongly linked with breast cancer susceptibility in Asian women. The Vanderbilt-Ingram Cancer Center investigators led by Dr.
A gene mutation could increase the potential of aggressive tumor development in men suffering from prostate cancer, U.S. researchers say. Dr.
Men who develop prostate cancer face an increased risk of having an aggressive tumor if they carry a so-called breast cancer gene mutation, scientists from the Albert Einstein College of Medicine of Yeshiva University report in today's issue of Clinical Cancer Research. The findings could help to guide prostate-cancer patients and their physicians in choosing treatment options.
Prophylactic salpingo-oophorectomyâ€”removal of the ovaries and fallopian tubes--reduces the relative risk of breast cancer by approximately 50 percent and the risk of ovarian and fallopian tube cancer by approximately 80 percent in women who carry a mutation in the BRCA1 or BRCA2 gene, researchers report in the January 13 online issue of the Journal of the National Cancer Institute.
Genetic tests that can detect a person's increased risk of breast, ovarian and prostate cancer are being offered in England, officials said. The Times of London reported Saturday that the genetic screenings are being offered for the first time to individuals without family histories of the diseases. The program, run by the University College London, paves the way for a new approach to preventative medicine and embryo screening by parents. News of the program came as Paul Serhal, medical...
A Canadian researcher has found that women with a family history of breast cancer can be at higher risk of the disease even if they are free of the most common breast cancer gene mutations.
- A young chicken: also used as a pet name for children.